Načítá se...
Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma
Follicular lymphoma (FL) is the most common type of indolent B-cell lymphoma. Twenty years ago, FL was considered an indolent lymphoma with a long survival time but without a high rate of complete remission with chemotherapies. The use of rituximab has improved the response and survival of patients...
Uloženo v:
| Vydáno v: | F1000Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
F1000 Research Limited
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6426075/ https://ncbi.nlm.nih.gov/pubmed/30906531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.16686.1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|